ACOR
Acorda Therapeutics Inc
Sign up for free!
Get instant access to stock market data and news with our free APIs.
Real-time data
- Listing exchange
- NASDAQ Stock Exchange
- Price
- $0.51
- Day High
- $0.58
- Day Low
- $0.51
- Day Open
- $0.58
- Volume
- 2075
- Day Change
- -5.88%
Latest news data for ACOR
Acorda Therapeutics launches 1-for-20 reverse stock split (NASDAQ:ACOR)
seekingalpha.com
MannKind Appoints Burkhard Blank as Chief Medical Officer By Investing.com
investing.com
3 Buy Worthy Biotech Stocks for May
entrepreneur.com
Global Multiple Sclerosis Drugs Market Sales to Top US$ 41 Billion by 2033; CAGR of 3.8%
globenewswire.com
Acorda Therapeutics, Inc. (ACOR) Q1 2023 Earnings Call Transcript
seekingalpha.com
Acorda Therapeutics, Inc. 2023 Q2 - Results - Earnings Call Presentation (NASDAQ:ACOR)
seekingalpha.com
Acorda Therapeutics down 8%, makes $6.2M interest payment in cash (NASDAQ:ACOR)
seekingalpha.com
Spasticity Treatment Market is set to reach US$ 28.4 Billion; with an expected CAGR of 8.1% through the forecast period 2033 end | Data by Future Market Insights, Inc.
globenewswire.com
Acorda Therapeutics and Chance Pharmaceuticals Announce Agreement to Commercialize INBRIJA® in China
marketscreener.com
Acorda First Quarter 2023 Update: Webcast/Conference Call Scheduled for May 11, 2023
marketscreener.com